Literature DB >> 33225514

Co-morbidity between mood and anxiety disorders: A systematic review and meta-analysis.

Sukanta Saha1,2, Carmen C W Lim1,2, Danielle L Cannon2, Lucinda Burton2, Monique Bremner2, Peter Cosgrove2, Yan Huo3, John J McGrath1,2,4.   

Abstract

There is consistent evidence that mood disorders often co-occur with anxiety disorders, however, the strength of the association of these two broad groups of disorders has been challenging to summarize across different studies. The aim was to conduct a meta-analysis of publications reporting on the pairwise comorbidity between mood and anxiety disorders after sorting into comparable study types. We searched MEDLINE, Embase, CINAHL, Web of Science, and the grey literature for publications between 1980 and 2017 regardless of geographical locations and languages. We meta-analyzed estimates from original articles after sorting by: (a) broad or narrow diagnostic criteria, (b) study time-frame, and (c) estimates with or without covariate adjustments. Over 43 000 unique studies were identified through electronic searches, of which 391 were selected for full-text review. Finally, 171 studies were eligible for inclusion, including 53 articles from additional snowball searching. In general, regardless of variations in diagnosis type, study time-frame, temporal order, or use of adjustments, there was substantial comorbidity between mood and anxiety disorders. Based on the entire 90 separate meta-analyses, the median OR was 6.1 (range 1.5-18.7). Of these estimates, all 90 were above 1, and 87 were significantly greater than 1 (i.e., the 95% confidence intervals did not include 1). Fourteen of the 90 pooled estimates had ORs that were greater than 10. This systematic review found robust and consistent evidence of comorbidity between broadly defined mood and anxiety disorders. Clinicians should be vigilant for the prompt identification and treatment of this common type of comorbidity.
© 2020 The Authors. Depression and Anxiety Published by Wiley Periodicals LLC.

Entities:  

Keywords:  agoraphobia; anxiety disorders; bipolar disorder; depression; epidemiology; mood disorder

Mesh:

Year:  2020        PMID: 33225514      PMCID: PMC7984258          DOI: 10.1002/da.23113

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  39 in total

1.  The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI).

Authors:  Ronald C Kessler; T Bedirhan Ustün
Journal:  Int J Methods Psychiatr Res       Date:  2004       Impact factor: 4.035

2.  Basics of meta-analysis: I2 is not an absolute measure of heterogeneity.

Authors:  Michael Borenstein; Julian P T Higgins; Larry V Hedges; Hannah R Rothstein
Journal:  Res Synth Methods       Date:  2017-01-06       Impact factor: 5.273

Review 3.  Comorbid Anxiety and Depressive Symptoms in Children and Adolescents: A Systematic Review and Analysis.

Authors:  Tabatha H Melton; Paul E Croarkin; Jeffrey R Strawn; Shawn M McClintock
Journal:  J Psychiatr Pract       Date:  2016-03       Impact factor: 1.325

4.  Predictors of treatment efficacy in a clinical trial of three psychosocial treatments for adolescent depression.

Authors:  D A Brent; D J Kolko; B Birmaher; M Baugher; J Bridge; C Roth; D Holder
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1998-09       Impact factor: 8.829

5.  Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey.

Authors:  R C Kessler; C B Nelson; K A McGonagle; J Liu; M Swartz; D G Blazer
Journal:  Br J Psychiatry Suppl       Date:  1996-06

6.  Adolescent psychopathology: IV. Specificity of psychosocial risk factors for depression and substance abuse in older adolescents.

Authors:  P M Lewinsohn; I H Gotlib; J R Seeley
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1995-09       Impact factor: 8.829

7.  The co-occurrence of major depressive disorder among individuals with posttraumatic stress disorder: a meta-analysis.

Authors:  Nina K Rytwinski; Michael D Scur; Norah C Feeny; Eric A Youngstrom
Journal:  J Trauma Stress       Date:  2013-05-20

8.  Reproducible Genetic Risk Loci for Anxiety: Results From ∼200,000 Participants in the Million Veteran Program.

Authors:  Daniel F Levey; Joel Gelernter; Renato Polimanti; Hang Zhou; Zhongshan Cheng; Mihaela Aslan; Rachel Quaden; John Concato; Krishnan Radhakrishnan; Julien Bryois; Patrick F Sullivan; Murray B Stein
Journal:  Am J Psychiatry       Date:  2020-01-07       Impact factor: 18.112

9.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.

Authors:  Larissa Shamseer; David Moher; Mike Clarke; Davina Ghersi; Alessandro Liberati; Mark Petticrew; Paul Shekelle; Lesley A Stewart
Journal:  BMJ       Date:  2015-01-02

10.  Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010.

Authors:  Alize J Ferrari; Fiona J Charlson; Rosana E Norman; Scott B Patten; Greg Freedman; Christopher J L Murray; Theo Vos; Harvey A Whiteford
Journal:  PLoS Med       Date:  2013-11-05       Impact factor: 11.069

View more
  12 in total

1.  Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited.

Authors:  Lucie Bartova; Markus Dold; Hans-Peter Volz; Erich Seifritz; Hans-Jürgen Möller; Siegfried Kasper
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-03-09       Impact factor: 5.270

2.  The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management.

Authors:  Roger S McIntyre; Martin Alda; Ross J Baldessarini; Michael Bauer; Michael Berk; Christoph U Correll; Andrea Fagiolini; Kostas Fountoulakis; Mark A Frye; Heinz Grunze; Lars V Kessing; David J Miklowitz; Gordon Parker; Robert M Post; Alan C Swann; Trisha Suppes; Eduard Vieta; Allan Young; Mario Maj
Journal:  World Psychiatry       Date:  2022-10       Impact factor: 79.683

Review 3.  An umbrella review on the use of antipsychotics in anxiety disorders: A registered report protocol.

Authors:  Amir Garakani; Rafael C Freire; Frank D Buono; Robyn P Thom; Kaitlyn Larkin; Melissa C Funaro; Mona Salehi; Mercedes M Perez-Rodriguez
Journal:  PLoS One       Date:  2022-06-16       Impact factor: 3.752

Review 4.  Co-morbidity between mood and anxiety disorders: A systematic review and meta-analysis.

Authors:  Sukanta Saha; Carmen C W Lim; Danielle L Cannon; Lucinda Burton; Monique Bremner; Peter Cosgrove; Yan Huo; John J McGrath
Journal:  Depress Anxiety       Date:  2020-11-22       Impact factor: 6.505

5.  Generalised Anxiety Disorder and Depression: Contemporary Treatment Approaches.

Authors:  Guy M Goodwin; Dan J Stein
Journal:  Adv Ther       Date:  2021-08-21       Impact factor: 3.845

Review 6.  Revisiting Treatment Options for Depressed Patients with Generalised Anxiety Disorder.

Authors:  Guy M Goodwin
Journal:  Adv Ther       Date:  2021-08-21       Impact factor: 3.845

7.  Overestimation and underestimation of youths' health-related quality of life are associated with youth and caregiver positive screens for depression: results of a population-based study among youths with longstanding type 1 diabetes.

Authors:  Anna Stahl-Pehe; Silvia Selinski; Christina Bächle; Katty Castillo; Karin Lange; Reinhard W Holl; Joachim Rosenbauer
Journal:  Diabetol Metab Syndr       Date:  2022-03-09       Impact factor: 3.320

8.  Comparison of depression and anxiety symptom networks in reporters and non-reporters of lifetime trauma in two samples of differing severity.

Authors:  Alicia J Peel; Chérie Armour; Joshua E J Buckman; Jonathan R I Coleman; Susannah C B Curzons; Molly R Davies; Christopher Hübel; Ian Jones; Gursharan Kalsi; Monika McAtarsney-Kovacs; Andrew M McIntosh; Dina Monssen; Jessica Mundy; Christopher Rayner; Henry C Rogers; Megan Skelton; Abigail Ter Kuile; Katherine N Thompson; Gerome Breen; Andrea Danese; Thalia C Eley
Journal:  J Affect Disord Rep       Date:  2021-12

9.  Effectiveness of vortioxetine in patients with major depressive disorder comorbid with generalized anxiety disorder: Results of the RECONNECT study.

Authors:  Michael Cronquist Christensen; Simon Schmidt; Iria Grande
Journal:  J Psychopharmacol       Date:  2022-05-02       Impact factor: 4.153

10.  Six-year prognosis of anxiety and depression caseness and their comorbidity in a prospective population-based adult sample.

Authors:  Olivia Stålner; Steven Nordin; Guy Madison
Journal:  BMC Public Health       Date:  2022-08-15       Impact factor: 4.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.